BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16043732)

  • 1. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.
    Liu J; Sempos C; Donahue RP; Dorn J; Trevisan M; Grundy SM
    Diabetes Care; 2005 Aug; 28(8):1916-21. PubMed ID: 16043732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.
    Liu J; Sempos CT; Donahue RP; Dorn J; Trevisan M; Grundy SM
    Am J Cardiol; 2006 Nov; 98(10):1363-8. PubMed ID: 17134630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.
    Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT
    J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.
    Winocour PH; Durrington PN; Bhatnagar D; Mbewu AD; Ishola M; Mackness M; Arrol S
    Diabetes Res Clin Pract; 1992 Dec; 18(3):173-84. PubMed ID: 1289018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.
    Schulze MB; Shai I; Manson JE; Li T; Rifai N; Jiang R; Hu FB
    Diabetologia; 2004 Dec; 47(12):2129-36. PubMed ID: 15662553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
    Sacks FM; Tonkin AM; Craven T; Pfeffer MA; Shepherd J; Keech A; Furberg CD; Braunwald E
    Circulation; 2002 Mar; 105(12):1424-8. PubMed ID: 11914249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of coronary heart disease using risk factor categories.
    Wilson PW; D'Agostino RB; Levy D; Belanger AM; Silbershatz H; Kannel WB
    Circulation; 1998 May; 97(18):1837-47. PubMed ID: 9603539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
    Laakso M; Lehto S; Penttilä I; Pyörälä K
    Circulation; 1993 Oct; 88(4 Pt 1):1421-30. PubMed ID: 8403288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
    Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
    Shepherd J; Barter P; Carmena R; Deedwania P; Fruchart JC; Haffner S; Hsia J; Breazna A; LaRosa J; Grundy S; Waters D
    Diabetes Care; 2006 Jun; 29(6):1220-6. PubMed ID: 16731999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population.
    Wang TD; Chen WJ; Chien KL; Seh-Yi Su SS; Hsu HC; Chen MF; Liau CS; Lee YT
    Am J Cardiol; 2001 Oct; 88(7):737-43. PubMed ID: 11589839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome?
    Windler E
    Atheroscler Suppl; 2005 Sep; 6(3):11-4. PubMed ID: 16046281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
    Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C
    Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study.
    Hu D; Jablonski KA; Sparling YH; Robbins DC; Lee ET; Welty TK; Howard BV
    Ann Epidemiol; 2002 Feb; 12(2):79-85. PubMed ID: 11880214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
    Soedamah-Muthu SS; Chaturvedi N; Toeller M; Ferriss B; Reboldi P; Michel G; Manes C; Fuller JH;
    Diabetes Care; 2004 Feb; 27(2):530-7. PubMed ID: 14747240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.